-
Purposelentiviral expression vector for dCas9 with Blasticidin selectable marker
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 85417 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backboneAddgene #61425
-
Modifications to backboneremoved VP64
-
Vector typeMammalian Expression, Lentiviral, CRISPR
-
Selectable markersBlasticidin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert namedCas9 and Blasticidin resistance
Resource Information
-
A portion of this plasmid was derived from a plasmid made byoriginal plasmid Addgene # 61425 From Feng Zhang lab was modified to remove VP64
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGH125_dCas9-Blast was a gift from Michael Bassik (Addgene plasmid # 85417 ; http://n2t.net/addgene:85417 ; RRID:Addgene_85417) -
For your References section:
Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells. Hess GT, Fresard L, Han K, Lee CH, Li A, Cimprich KA, Montgomery SB, Bassik MC. Nat Methods. 2016 Oct 31. doi: 10.1038/nmeth.4038. 10.1038/nmeth.4038 PubMed 27798611